Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some ...

Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a moderated digital poster presentation at ...

Some genetic disorders—such as cystic fibrosis, hemophilia and Tay Sachs disease—involve many mutations in a person's genome, ...

Biotech company Metagenomi (NASDAQ:MGX) is utilizing artificial intelligence chips from Amazon Web Services (AMZN) to enhance ...

The press release will be available in the Investors section of Cellectis’ website: Cellectis will not host a conference call to discuss these results. Our investors relations team remains available ...

Preliminary data recently shared for eti-cel (UCART20x22) show an 86% ORR and a 57% CR rate (n=7), underscoring its potential to improve outcomes ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics Ltd. (Nasd ...

The collaboration will progress under the combined company, NewCelX, upon completion of the anticipated merger ZURICH and NESS ZIONA, Israel, Oct. 27, 2025 /PRNewswire/ -- NLS Pharmaceutics ...

Keywords: Gene editing, Neglected crops, CRISPR-Cas9 ... A fee support application form is available on our website. Will there be a printed version of my Research Topic? In line with our mission to ...

An international research project, involving the University of Adelaide, discovered the gene responsible for a rare form of wheat that grows three ...

Press Democrat readers share their thoughts on the president, the federal shutdown, resistance movements and Democrats ...

The world’s largest network of environmental groups approved the exploration of genetic engineering tools to aid the ...